NSRX

Nasus Pharma Ltd.

AMEX: NSRX · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$3.03

-4.72% today

Updated 2026-07-31

Market cap

$36.19M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.72

Dividend yield

—

52W range

$0 – $10

Volume

0.0M

Market cap

$36.19M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.72

Dividend yield

—

52W range

$0 – $10

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.5

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →205 stocks currently score above 75

Price targets

Analyst target

$19.67

+549.17%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-4.93M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-1.71M	$-1.05M	$-1.53M	$-5.86M	$-5.86M
EPS	—	—	—	—	$-0.72
Free cash flow	$-1.21M	$-1.03M	$-665000.00	$-4.93M	$-4.93M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NSRX	$36.19M	18	4.3	3.5	5.0	6.0	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Nasus Pharma Ltd. trades at $3.03. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score.

Frequently asked questions

What is Nasus Pharma Ltd.'s stock price?

Nasus Pharma Ltd. (NSRX) trades at $3.03.

Is Nasus Pharma Ltd. overvalued?

Nasus Pharma Ltd. carries a Smart Value Score of 18/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Nasus Pharma Ltd. (NSRX)?

The 12-month analyst consensus target is $19.67, about 549.2% above the current $3.03. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - GENERAL

CountryUSA

ExchangeAMEX

CurrencyUSD

Quick metrics

P/S ratio—

ROE—

Beta—

50D MA$3.10

200D MA$4.96

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NSRX vs LLY →NSRX vs JNJ →NSRX vs ABBV →Stock screener →